22:08:35 EST Wed 21 Feb 2018
Enter Symbol
or Name

Symbol U : VVUS
Recent Sedar Documents

VIVUS to Present at Three Investor Conferences in February 2013

2013-02-08 07:00 ET - News Release

MOUNTAIN VIEW, Calif., Feb. 8, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that Timothy E. Morris, chief financial officer, will present an overview of the company at three investment conferences during the month of February 2013.

The conference presentation schedule is as follows:           

Leerink Swann 2013 Global Healthcare Conference
February 13, 2013, 12:00 noon EST
Waldorf Astoria Hotel
New York, NY
Citi Equities 2013 Global Healthcare Conference
February 27, 2013, 11:05am EST
Hilton New York
New York, NY
RBC Capital Markets Healthcare Conference
February 27, 2013, 2:00pm EST
New York Palace Hotel
New York, NY

A live webcast and 30-day archive of the presentations will be available at http://ir.vivus.com.


VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health for U.S., Europe and other world markets.  For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2011, and periodic reports filed with the Securities and Exchange Commission.

         Timothy E. Morris
         Chief Financial Officer

         Financial Media Relations:
         Joele Frank, Wilkinson Brimmer Katcher
         Eric Bonach

         Investor Relations:
         The Trout Group 
         Brian Korb

© 2018 Canjex Publishing Ltd. All rights reserved.